{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:19:41Z","timestamp":1793272781409,"version":"4.5.0"},"reference-count":143,"publisher":"Informa UK Limited","issue":"10","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2025,10,3]]},"DOI":"10.1080\/13543784.2025.2573647","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T14:16:11Z","timestamp":1760019371000},"page":"755-773","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Androgen receptor pathway signaling inhibitors in development for prostate cancer therapy"],"prefix":"10.1080","volume":"34","author":[{"given":"Sara","family":"Bleve","sequence":"first","affiliation":[{"name":"Weill Cornell Medical College","place":["New York, USA"]},{"name":"IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d","place":["Meldola"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5618-8079","authenticated-orcid":false,"given":"Pier Vitale","family":"Nuzzo","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Baseet","family":"Arham","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Holmes","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2777-8587","authenticated-orcid":false,"given":"Scott T.","family":"Tagawa","sequence":"additional","affiliation":[{"name":"Weill Cornell Medical College","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2214122"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615869"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311593"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-194206000-00030"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014618"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207506"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-4683.2015.05.02"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.06.042"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt138"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt136"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.07.028"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911206"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.23736\/S0393-2249.17.03066-1"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03939.x"},{"issue":"27","key":"e_1_3_5_19_1","first-page":"11","article-title":"Androgen deprivation therapy: indications, methods of utilization, side effects and their management","volume":"27","author":"Magee DE","year":"2020","unstructured":"Magee DE, Singal RK. Androgen deprivation therapy: indications, methods of utilization, side effects and their management. Can J Urol. 2020;27(27 Suppl 1):11\u201316.","journal-title":"Can J Urol"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11774.x"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad055"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0120"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.06.042"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02759"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44514-2"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23209"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab361"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01548"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.5011"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.1722"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.08.034"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.1686"},{"key":"e_1_3_5_33_1","unstructured":"AstraZeneca PLC. Update on CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer. 2025."},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.1684"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3353727"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6339"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.10.018"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0110281"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc4016"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030452"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21043"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3419"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)36163-3"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00279-3"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25102448"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1168175"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.07.032"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2003892"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.08.011"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001342"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30898-2"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5515"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5516"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113258"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903835"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00799"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03488"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119115"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-01798"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303974"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01157"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2279"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.08.053"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11125"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22046"},{"key":"e_1_3_5_66_1","first-page":"H1","volume-title":"Faculty opinions \u2013 post-publication peer review of the biomedical literature","author":"Bevan C","year":"2016","unstructured":"Bevan C, Brooke G. Faculty opinions recommendation of integrative clinical genomics of advanced prostate cancer. In: Angela CP, Flavia FF, editors. Faculty opinions \u2013 post-publication peer review of the biomedical literature. Connect: H1Connect; 2016. p. H1."},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.11.012"},{"key":"e_1_3_5_68_1","volume-title":"2021 ASCO Annual Meeting","author":"Bono JSD","year":"2021","unstructured":"Bono JSD, Cook N, Yu EY, et al. First-in-human study of TAS3681, an oral androgen receptor (AR) antagonist with AR and AR splice variant (AR-SV) downregulation activity, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) refractory to abiraterone (ABI) and\/or enzalutamide (ENZ) and chemotherapy (CT). In: 2021 ASCO Annual Meeting; Chicago, IL, USA; 2021."},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.e16542"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34512"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-24-0208"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9120166"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.03.073"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22504"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2017.1360645"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.151390"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1210\/mend.12.7.0136"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-022-00636-0"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.178"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.218"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00686-y"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2021.08.001"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15135"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2017.06.013"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gls078"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13539-011-0034-6"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70055-X"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.04.007"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.02.005"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0084-3741(09)79434-X"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00099"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2020.115554"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104500"},{"key":"e_1_3_5_94_1","author":"Snyder LB","year":"2025","unstructured":"Snyder LB, Neklesa TK, Willard RR, et al. Data from preclinical evaluation of bavdegalutamide (ARV-110), a novel PROteolysis TArgeting chimera androgen receptor degrader. 2025.","journal-title":"Data from preclinical evaluation of bavdegalutamide (ARV-110), a novel PROteolysis TArgeting chimera androgen receptor degrader"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030663"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.235"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-97-5077-1_11"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.09.005"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-025-01533-8"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0161"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-021-01202-6"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.12.005"},{"key":"e_1_3_5_103_1","unstructured":"ESSA Pharma announces termination of phase 2 study evaluating masofaniten combined with enzalutamide in patients with metastatic castration-resistant prostate cancer. news release. ESSA Pharma Inc; 2024 Oct 31 [cited 2024 Nov 1]. Available from: https:\/\/investors.essapharma.com\/2024-10-31-ESSA-Pharma-Announces-Termination-of-Phase-2-Study-Evaluating-Masofaniten-Combined-with-Enzalutamide-in-Patients-with-Metastatic-Castration-Resistant-Prostate-Cancer"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-015-0235-5"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4578"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-1432"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1530\/EO-24-0061"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2189"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70027-6"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.5119"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02517"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-018-0077-y"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2018.02.004"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.08.022"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-1683(24)01264-3"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0115"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300171"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.05.026"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.001"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2018.9"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200800113"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.530"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2013.05.007"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.03.040"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.08.015"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10912"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2017.01.024"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.03.005"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0981"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.2250"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.01.074"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114103"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01576"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.05.019"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01075"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4045"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.TPS335"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_suppl.3094"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.LBA138"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041318"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.08.021"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.8751"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.4487"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.8648"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-01003-9"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2025.2573647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:37:55Z","timestamp":1763138275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2025.2573647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"alternative-id":["10.1080\/13543784.2025.2573647"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2025.2573647","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}